Related Experiment Video
Updated: May 25, 2026

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery
Published on: May 19, 2018
Induced pluripotent stem cells as a disease modeling and drug screening platform
Antje D Ebert1, Ping Liang, Joseph C Wu
1Division of Cardiology, Departments of Medicine, Stanford University, Stanford, CA 94305-5454, USA.
None:
Induced pluripotent stem cells (iPSCs) hold great hopes for therapeutic application in various diseases. Although ongoing research is dedicated to achieving clinical translation of iPSCs, further understanding of the mechanisms that underlie complex pathogenic conditions is required. Compared with other classical models for studying diseases, iPSCs provide considerable advantages. A newly emerging application of iPSCs is in vitro disease modeling, which can significantly improve the never-ending search for new pharmacological cures. Here, we will discuss current efforts to create iPSC-dependent patient-specific disease models. Furthermore, we will review the use of iPSCs for development and testing of new therapeutic agents and the implications for high-throughput drug screening.
More Related Videos
Related Concept Videos
EPS and iPS Cells in Disease Research
Induced Pluripotent Stem Cells
Somatic cells are...
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
iPS Cell Differentiation

